0000000000538305

AUTHOR

Antonella Cappelli

showing 2 related works from this author

The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients

2021

Abstract Objective Various studies have shown that overweight and obesity are central features of FM, but the real impact of a high BMI on clinical severity in patients with FM is still controversial. The aim of this study was to analyse the relationships between BMI categories and measures of symptom severity and functional impairment using data from a Web-based registry of patients with FM. Methods Adult patients with an ACR 2010/2011 diagnosis of FM underwent a complete physical examination and laboratory tests and were asked to complete a package of questionnaires covering their sociodemographic and treatment details, in addition to the following disease-specific questionnaires: the rev…

medicine.medical_specialtyobesityCross-sectional studyRevised Fibromyalgia Impact QuestionnaireOverweightNO03 medical and health sciencesBMI0302 clinical medicineRheumatologyInternal medicineFibromyalgiamedicineLS4_5030212 general & internal medicine030203 arthritis & rheumatologybusiness.industrymedicine.diseaseObesityDistressclinical severitywidespread painOriginal ArticlefibromyalgiaUnderweightmedicine.symptomAcademicSubjects/MED00010businessBody mass indexBMI; clinical severity; fibromyalgia; obesity; widespread pain
researchProduct

Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database

2021

ObjectiveThe role of age in influencing the severity of fibromyalgia (FM) is still controversial. The aim of this study is to define the contribution of age in the severity of FM from data from a large national database.MethodsThis cross-sectional study included adult patients with FM diagnosed according to the 2010/2011 American College of Rheumatology criteria. Disease severity was assessed with the revised Fibromyalgia Impact Questionnaire (FIQR) and the modified Fibromyalgia Assessment Status (FAS 2019mod). Patients were grouped into five age categories (between 18-40 years, between 41- 50 years, between 51-60 years, between 61-70 years, and =71 years). Differences in disease severity b…

AdultMaleSettore MED/16 - REUMATOLOGIAAdolescentImmunologyReproducibility of ResultsMiddle AgedFAS 2019mod.Severity of Illness IndexYoung AdultCross-Sectional StudiesRheumatologyagenational databaseSurveys and QuestionnairesQuality of LifeImmunology and AllergyHumansdisease severityFemalefibromyalgiaFIQR
researchProduct